Global Partnerships and Collaborations Validate Our Platform

We are establishing a global network of partnerships and collaborations – from discovery to development.  These alliances leverage our AI-powered antibody technology platform to help bring innovative therapeutics to patients.  Meanwhile, key clinical collaborations enable advancement of our internal wholly-owned pipeline candidates.

SAFEbody Development
DPL Discovery
Clinical Collaborations
Validation by Chinese Entities